Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]
Clinical data | |
---|---|
Trade names | Soleton |
Other names | Zaxoprofen |
Drug class | NSAID |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.070.863 |
Chemical and physical data | |
Formula | C17H14O3S |
Molar mass | 298.36 g·mol−1 |
3D model (JSmol) |
|
|
It was approved for use in Japan in 1993.[3]